nodes	percent_of_prediction	percent_of_DWPC	metapath
Flutamide—Metastatic carcinoma—Topotecan—cervical cancer	0.332	0.522	CcSEcCtD
Flutamide—Metastatic neoplasm—Topotecan—cervical cancer	0.083	0.13	CcSEcCtD
Flutamide—AR—semen—cervical cancer	0.0414	0.125	CbGeAlD
Flutamide—Bullous eruption—Topotecan—cervical cancer	0.0402	0.0632	CcSEcCtD
Flutamide—Interstitial lung disease—Topotecan—cervical cancer	0.0225	0.0353	CcSEcCtD
Flutamide—Pulmonary embolism—Topotecan—cervical cancer	0.0159	0.025	CcSEcCtD
Flutamide—AHR—uterine cervix—cervical cancer	0.0153	0.0462	CbGeAlD
Flutamide—AHR—decidua—cervical cancer	0.0146	0.0441	CbGeAlD
Flutamide—Neoplasm—Topotecan—cervical cancer	0.0144	0.0226	CcSEcCtD
Flutamide—AHR—endometrium—cervical cancer	0.0139	0.0418	CbGeAlD
Flutamide—AHR—mammalian vulva—cervical cancer	0.0134	0.0405	CbGeAlD
Flutamide—AHR—uterus—cervical cancer	0.0128	0.0385	CbGeAlD
Flutamide—Dermatitis bullous—Topotecan—cervical cancer	0.0121	0.019	CcSEcCtD
Flutamide—AHR—female reproductive system—cervical cancer	0.0115	0.0346	CbGeAlD
Flutamide—AHR—female gonad—cervical cancer	0.0105	0.0315	CbGeAlD
Flutamide—AHR—vagina—cervical cancer	0.0104	0.0313	CbGeAlD
Flutamide—Aspartate aminotransferase increased—Topotecan—cervical cancer	0.0104	0.0163	CcSEcCtD
Flutamide—AR—epithelium—cervical cancer	0.00763	0.023	CbGeAlD
Flutamide—CYP1B1—decidua—cervical cancer	0.00761	0.023	CbGeAlD
Flutamide—AR—uterine cervix—cervical cancer	0.00757	0.0228	CbGeAlD
Flutamide—CYP1B1—renal system—cervical cancer	0.00748	0.0225	CbGeAlD
Flutamide—AR—decidua—cervical cancer	0.00721	0.0217	CbGeAlD
Flutamide—AR—renal system—cervical cancer	0.00708	0.0213	CbGeAlD
Flutamide—AR—endometrium—cervical cancer	0.00684	0.0206	CbGeAlD
Flutamide—AHR—lymph node—cervical cancer	0.00672	0.0203	CbGeAlD
Flutamide—CYP1B1—uterus—cervical cancer	0.00666	0.0201	CbGeAlD
Flutamide—AR—mammalian vulva—cervical cancer	0.00662	0.02	CbGeAlD
Flutamide—Ill-defined disorder—Topotecan—cervical cancer	0.00645	0.0101	CcSEcCtD
Flutamide—Anaemia—Topotecan—cervical cancer	0.00643	0.0101	CcSEcCtD
Flutamide—AR—uterus—cervical cancer	0.00631	0.019	CbGeAlD
Flutamide—Malaise—Topotecan—cervical cancer	0.00627	0.00984	CcSEcCtD
Flutamide—Leukopenia—Topotecan—cervical cancer	0.00622	0.00977	CcSEcCtD
Flutamide—CYP1B1—female reproductive system—cervical cancer	0.00599	0.018	CbGeAlD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Topotecan—cervical cancer	0.00588	0.00923	CcSEcCtD
Flutamide—Discomfort—Topotecan—cervical cancer	0.00585	0.00918	CcSEcCtD
Flutamide—CYP1A1—epithelium—cervical cancer	0.0057	0.0172	CbGeAlD
Flutamide—AR—female reproductive system—cervical cancer	0.00567	0.0171	CbGeAlD
Flutamide—CYP1A1—uterine cervix—cervical cancer	0.00565	0.017	CbGeAlD
Flutamide—Thrombocytopenia—Topotecan—cervical cancer	0.00556	0.00872	CcSEcCtD
Flutamide—CYP3A5—uterine cervix—cervical cancer	0.00552	0.0167	CbGeAlD
Flutamide—Skin disorder—Topotecan—cervical cancer	0.00551	0.00865	CcSEcCtD
Flutamide—CYP1B1—female gonad—cervical cancer	0.00545	0.0164	CbGeAlD
Flutamide—Anorexia—Topotecan—cervical cancer	0.00541	0.00849	CcSEcCtD
Flutamide—CYP1A2—renal system—cervical cancer	0.00536	0.0162	CbGeAlD
Flutamide—CYP1A1—renal system—cervical cancer	0.00529	0.0159	CbGeAlD
Flutamide—CYP3A5—renal system—cervical cancer	0.00517	0.0156	CbGeAlD
Flutamide—AR—female gonad—cervical cancer	0.00516	0.0156	CbGeAlD
Flutamide—AR—vagina—cervical cancer	0.00513	0.0155	CbGeAlD
Flutamide—CYP1A1—mammalian vulva—cervical cancer	0.00494	0.0149	CbGeAlD
Flutamide—Decreased appetite—Topotecan—cervical cancer	0.00493	0.00774	CcSEcCtD
Flutamide—Fatigue—Topotecan—cervical cancer	0.00489	0.00768	CcSEcCtD
Flutamide—Constipation—Topotecan—cervical cancer	0.00485	0.00762	CcSEcCtD
Flutamide—CYP2C19—vagina—cervical cancer	0.00475	0.0143	CbGeAlD
Flutamide—CYP1A1—uterus—cervical cancer	0.00471	0.0142	CbGeAlD
Flutamide—Feeling abnormal—Topotecan—cervical cancer	0.00468	0.00734	CcSEcCtD
Flutamide—CYP1A1—female reproductive system—cervical cancer	0.00423	0.0128	CbGeAlD
Flutamide—Asthenia—Topotecan—cervical cancer	0.00407	0.00639	CcSEcCtD
Flutamide—Pruritus—Topotecan—cervical cancer	0.00401	0.0063	CcSEcCtD
Flutamide—Diarrhoea—Topotecan—cervical cancer	0.00388	0.00609	CcSEcCtD
Flutamide—CYP3A4—renal system—cervical cancer	0.00388	0.0117	CbGeAlD
Flutamide—CYP1A1—female gonad—cervical cancer	0.00385	0.0116	CbGeAlD
Flutamide—CYP1A1—vagina—cervical cancer	0.00383	0.0115	CbGeAlD
Flutamide—CYP3A5—female gonad—cervical cancer	0.00377	0.0114	CbGeAlD
Flutamide—Dizziness—Topotecan—cervical cancer	0.00375	0.00589	CcSEcCtD
Flutamide—CYP3A5—vagina—cervical cancer	0.00374	0.0113	CbGeAlD
Flutamide—Vomiting—Topotecan—cervical cancer	0.00361	0.00566	CcSEcCtD
Flutamide—Rash—Topotecan—cervical cancer	0.00358	0.00562	CcSEcCtD
Flutamide—Dermatitis—Topotecan—cervical cancer	0.00357	0.00561	CcSEcCtD
Flutamide—Headache—Topotecan—cervical cancer	0.00355	0.00558	CcSEcCtD
Flutamide—CYP1B1—lymph node—cervical cancer	0.0035	0.0106	CbGeAlD
Flutamide—Nausea—Topotecan—cervical cancer	0.00337	0.00529	CcSEcCtD
Flutamide—AR—lymph node—cervical cancer	0.00332	0.01	CbGeAlD
Flutamide—CYP3A4—female reproductive system—cervical cancer	0.00311	0.00936	CbGeAlD
Flutamide—CYP1A1—lymph node—cervical cancer	0.00248	0.00746	CbGeAlD
Flutamide—AHR—Aryl Hydrocarbon Receptor Pathway—HES1—cervical cancer	0.00184	0.0591	CbGpPWpGaD
Flutamide—AR—Notch-mediated HES/HEY network—YY1—cervical cancer	0.0018	0.0578	CbGpPWpGaD
Flutamide—AR—Coregulation of Androgen receptor activity—PIAS3—cervical cancer	0.00175	0.056	CbGpPWpGaD
Flutamide—AR—Regulation of nuclear SMAD2/3 signaling—PIAS3—cervical cancer	0.00139	0.0446	CbGpPWpGaD
Flutamide—AR—Nuclear Receptors—RARB—cervical cancer	0.00134	0.0429	CbGpPWpGaD
Flutamide—AR—Androgen receptor signaling pathway—PIAS3—cervical cancer	0.00129	0.0414	CbGpPWpGaD
Flutamide—AHR—Circadian rythm related genes—UBE3A—cervical cancer	0.00128	0.041	CbGpPWpGaD
Flutamide—CYP1B1—Tryptophan metabolism—UBE3A—cervical cancer	0.00117	0.0375	CbGpPWpGaD
Flutamide—AR—Coregulation of Androgen receptor activity—UBE3A—cervical cancer	0.00113	0.0361	CbGpPWpGaD
Flutamide—AR—Nuclear Receptor transcription pathway—RARB—cervical cancer	0.00106	0.0339	CbGpPWpGaD
Flutamide—AR—Androgen receptor signaling pathway—UBE3A—cervical cancer	0.000832	0.0267	CbGpPWpGaD
Flutamide—AHR—Aryl Hydrocarbon Receptor—EGFR—cervical cancer	0.000733	0.0235	CbGpPWpGaD
Flutamide—AHR—Aryl Hydrocarbon Receptor Pathway—EGFR—cervical cancer	0.000733	0.0235	CbGpPWpGaD
Flutamide—CYP1A1—Tryptophan metabolism—UBE3A—cervical cancer	0.00072	0.0231	CbGpPWpGaD
Flutamide—CYP1B1—Estrogen Receptor Pathway—STAT3—cervical cancer	0.000622	0.0199	CbGpPWpGaD
Flutamide—AR—Notch-mediated HES/HEY network—HES1—cervical cancer	0.000614	0.0197	CbGpPWpGaD
Flutamide—CYP1B1—Aryl Hydrocarbon Receptor Pathway—HES1—cervical cancer	0.000517	0.0166	CbGpPWpGaD
Flutamide—AHR—Integrated Breast Cancer Pathway—CASP8—cervical cancer	0.00049	0.0157	CbGpPWpGaD
Flutamide—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.000476	0.0153	CbGpPWpGaD
Flutamide—AR—Notch-mediated HES/HEY network—NOTCH1—cervical cancer	0.000463	0.0149	CbGpPWpGaD
Flutamide—CYP1A2—Tryptophan metabolism—UBE3A—cervical cancer	0.000459	0.0147	CbGpPWpGaD
Flutamide—AHR—Integrated Breast Cancer Pathway—MTOR—cervical cancer	0.000403	0.0129	CbGpPWpGaD
Flutamide—AHR—Adipogenesis—CTNNB1—cervical cancer	0.000403	0.0129	CbGpPWpGaD
Flutamide—CYP1A1—Estrogen Receptor Pathway—STAT3—cervical cancer	0.000383	0.0123	CbGpPWpGaD
Flutamide—AHR—Integrated Breast Cancer Pathway—CASP3—cervical cancer	0.000371	0.0119	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—RARB—cervical cancer	0.000368	0.0118	CbGpPWpGaD
Flutamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.000368	0.0118	CbGpPWpGaD
Flutamide—AHR—Integrated Breast Cancer Pathway—CTNNB1—cervical cancer	0.000357	0.0115	CbGpPWpGaD
Flutamide—CYP3A4—Tryptophan metabolism—UBE3A—cervical cancer	0.000354	0.0114	CbGpPWpGaD
Flutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—TERT—cervical cancer	0.000351	0.0113	CbGpPWpGaD
Flutamide—AHR—Adipogenesis—STAT3—cervical cancer	0.000351	0.0113	CbGpPWpGaD
Flutamide—AR—Notch-mediated HES/HEY network—CD4—cervical cancer	0.000347	0.0111	CbGpPWpGaD
Flutamide—AR—Coregulation of Androgen receptor activity—CASP8—cervical cancer	0.000343	0.011	CbGpPWpGaD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor Pathway—HES1—cervical cancer	0.000319	0.0102	CbGpPWpGaD
Flutamide—AHR—Integrated Breast Cancer Pathway—EGFR—cervical cancer	0.000283	0.00908	CbGpPWpGaD
Flutamide—AR—Notch-mediated HES/HEY network—STAT3—cervical cancer	0.000268	0.0086	CbGpPWpGaD
Flutamide—AR—Coregulation of Androgen receptor activity—CTNNB1—cervical cancer	0.00025	0.00801	CbGpPWpGaD
Flutamide—CYP1A2—Estrogen Receptor Pathway—STAT3—cervical cancer	0.000244	0.00782	CbGpPWpGaD
Flutamide—AHR—Integrated Breast Cancer Pathway—TP53—cervical cancer	0.000238	0.00762	CbGpPWpGaD
Flutamide—AR—SIDS Susceptibility Pathways—HES1—cervical cancer	0.000235	0.00753	CbGpPWpGaD
Flutamide—CYP1B1—Aryl Hydrocarbon Receptor—EGFR—cervical cancer	0.000206	0.00659	CbGpPWpGaD
Flutamide—CYP1B1—Aryl Hydrocarbon Receptor Pathway—EGFR—cervical cancer	0.000206	0.00659	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—cervical cancer	0.000203	0.00651	CbGpPWpGaD
Flutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—cervical cancer	0.000201	0.00645	CbGpPWpGaD
Flutamide—AHR—Circadian rythm related genes—TP53—cervical cancer	0.000189	0.00606	CbGpPWpGaD
Flutamide—AR—Androgen receptor signaling pathway—CTNNB1—cervical cancer	0.000185	0.00592	CbGpPWpGaD
Flutamide—AR—Generic Transcription Pathway—RARB—cervical cancer	0.000183	0.00586	CbGpPWpGaD
Flutamide—AR—Integrated Breast Cancer Pathway—CASP8—cervical cancer	0.000166	0.00532	CbGpPWpGaD
Flutamide—AR—Androgen receptor signaling pathway—STAT3—cervical cancer	0.000161	0.00516	CbGpPWpGaD
Flutamide—AR—Androgen receptor signaling pathway—EGFR—cervical cancer	0.000146	0.00469	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—CASP8—cervical cancer	0.000137	0.00441	CbGpPWpGaD
Flutamide—AR—Integrated Breast Cancer Pathway—MTOR—cervical cancer	0.000136	0.00437	CbGpPWpGaD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—cervical cancer	0.000127	0.00406	CbGpPWpGaD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—cervical cancer	0.000127	0.00406	CbGpPWpGaD
Flutamide—AR—Integrated Breast Cancer Pathway—CASP3—cervical cancer	0.000126	0.00402	CbGpPWpGaD
Flutamide—AR—SIDS Susceptibility Pathways—CASP3—cervical cancer	0.000122	0.00392	CbGpPWpGaD
Flutamide—AR—Generic Transcription Pathway—NOTCH2—cervical cancer	0.000121	0.00388	CbGpPWpGaD
Flutamide—AR—Integrated Breast Cancer Pathway—CTNNB1—cervical cancer	0.000121	0.00388	CbGpPWpGaD
Flutamide—AR—SIDS Susceptibility Pathways—CTNNB1—cervical cancer	0.000118	0.00378	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—CASP3—cervical cancer	0.000104	0.00333	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—cervical cancer	0.0001	0.00321	CbGpPWpGaD
Flutamide—AR—Integrated Breast Cancer Pathway—EGFR—cervical cancer	9.59e-05	0.00307	CbGpPWpGaD
Flutamide—AR—Gene Expression—RARB—cervical cancer	8.8e-05	0.00282	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—cervical cancer	8.07e-05	0.00259	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—cervical cancer	8.07e-05	0.00259	CbGpPWpGaD
Flutamide—AR—Integrated Breast Cancer Pathway—TP53—cervical cancer	8.05e-05	0.00258	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	7.94e-05	0.00255	CbGpPWpGaD
Flutamide—AR—Generic Transcription Pathway—NOTCH1—cervical cancer	7.5e-05	0.0024	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—CA9—cervical cancer	6.67e-05	0.00214	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	6.67e-05	0.00214	CbGpPWpGaD
Flutamide—AR—Gene Expression—NOTCH2—cervical cancer	5.83e-05	0.00187	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—CA9—cervical cancer	4.35e-05	0.00139	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—CA9—cervical cancer	4.11e-05	0.00132	CbGpPWpGaD
Flutamide—AR—Gene Expression—NOTCH1—cervical cancer	3.61e-05	0.00116	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—CA9—cervical cancer	3.36e-05	0.00108	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—MTHFR—cervical cancer	2.71e-05	0.000868	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—CA9—cervical cancer	2.62e-05	0.00084	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—CA9—cervical cancer	2.02e-05	0.000648	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—MTHFR—cervical cancer	1.76e-05	0.000566	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—MTHFR—cervical cancer	1.67e-05	0.000534	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—MTHFR—cervical cancer	1.36e-05	0.000437	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—MTHFR—cervical cancer	1.06e-05	0.000341	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—MTHFR—cervical cancer	8.2e-06	0.000263	CbGpPWpGaD
